Brett K. Haumann, SVP Clin Development & Chief Med Ofc at Theravance Biopharma, Inc. (TBPH), sold 27,576 shares at $31.52 ($869K) on 2017-03-06, disclosed to the SEC on 2017-03-08.
Open-market sale of $869k TBPH by SVP Clin Development & Chief Med Ofc. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.52 | 13,576 | $428K | 49.2% |
| 2 | $31.52 | 13,576 | $428K | 49.2% |
| 3 | $30.80 | 424 | $13K | 1.5% |
| Total | $31.51 avg | 27,576 | $869K | 100% |
| Filing → |
| TBPH | SELL | 2016-08-23 | $266K | — | Filing → |